The liver X receptor agonist LXR 623 restricts flavivirus replication
The vector-borne flaviviruses (VBFVs) are well known for causing great misery and death in humans worldwide. The VBFVs include those transmitted by mosquitos, such as Zika virus (ZIKV), dengue virus; and those transmitted by ticks including the tick-borne flavivirus serocomplex and Powassan virus (P...
Saved in:
| Published in | Emerging microbes & infections Vol. 10; no. 1; pp. 1378 - 1389 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Taylor & Francis
01.01.2021
Taylor & Francis Ltd Taylor & Francis Group |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The vector-borne flaviviruses (VBFVs) are well known for causing great misery and death in humans worldwide. The VBFVs include those transmitted by mosquitos, such as Zika virus (ZIKV), dengue virus; and those transmitted by ticks including the tick-borne flavivirus serocomplex and Powassan virus (POWV). Two of our recent reports showed that intracranial POWV infection in the reservoir host, Peromyscus leucopus, was restricted and caused no overt clinical disease. Several modes of analyses suggested activation of the LXR pathway. Activation of the LXR pathway leads to increased efflux of cholesterol from cells and consequent disturbances in membrane biogenesis. Because VBFV replication is dependent on membrane biogenesis, we evaluated the effect of an LXR agonist (LXR623) on POWV and ZIKV infection and observed that the compound impaired permissive replication of both viruses in a human neuroblastoma SK-N-SH cell line. The LXR agonist resulted in failure of the viruses to induce ER expansion and elaborate vesicle formation, suggesting that the efflux of cholesterol was part of the antiviral mechanism. We also observed that the LXR agonist contributed to the mechanism of virus suppression by increased expression of mRNAs encoding for the antiviral cytokines CXCL10, RANTES and IFN1β. In sharp contrast, a LXR antagonist (GSK2033) had no significant effect on VBFV replication. We conclude that LXR623 impairs flavivirus replication by stimulating cellular antiviral factors. |
|---|---|
| AbstractList | The vector-borne flaviviruses (VBFVs) are well known for causing great misery and death in humans worldwide. The VBFVs include those transmitted by mosquitos, such as Zika virus (ZIKV), dengue virus; and those transmitted by ticks including the tick-borne flavivirus serocomplex and Powassan virus (POWV). Two of our recent reports showed that intracranial POWV infection in the reservoir host, Peromyscus leucopus, was restricted and caused no overt clinical disease. Several modes of analyses suggested activation of the LXR pathway. Activation of the LXR pathway leads to increased efflux of cholesterol from cells and consequent disturbances in membrane biogenesis. Because VBFV replication is dependent on membrane biogenesis, we evaluated the effect of an LXR agonist (LXR623) on POWV and ZIKV infection and observed that the compound impaired permissive replication of both viruses in a human neuroblastoma SK-N-SH cell line. The LXR agonist resulted in failure of the viruses to induce ER expansion and elaborate vesicle formation, suggesting that the efflux of cholesterol was part of the antiviral mechanism. We also observed that the LXR agonist contributed to the mechanism of virus suppression by increased expression of mRNAs encoding for the antiviral cytokines CXCL10, RANTES and IFN1β. In sharp contrast, a LXR antagonist (GSK2033) had no significant effect on VBFV replication. We conclude that LXR623 impairs flavivirus replication by stimulating cellular antiviral factors. The vector-borne flaviviruses (VBFVs) are well known for causing great misery and death in humans worldwide. The VBFVs include those transmitted by mosquitos, such as Zika virus (ZIKV), dengue virus; and those transmitted by ticks including the tick-borne flavivirus serocomplex and Powassan virus (POWV). Two of our recent reports showed that intracranial POWV infection in the reservoir host, Peromyscus leucopus , was restricted and caused no overt clinical disease. Several modes of analyses suggested activation of the LXR pathway. Activation of the LXR pathway leads to increased efflux of cholesterol from cells and consequent disturbances in membrane biogenesis. Because VBFV replication is dependent on membrane biogenesis, we evaluated the effect of an LXR agonist (LXR623) on POWV and ZIKV infection and observed that the compound impaired permissive replication of both viruses in a human neuroblastoma SK-N-SH cell line. The LXR agonist resulted in failure of the viruses to induce ER expansion and elaborate vesicle formation, suggesting that the efflux of cholesterol was part of the antiviral mechanism. We also observed that the LXR agonist contributed to the mechanism of virus suppression by increased expression of mRNAs encoding for the antiviral cytokines CXCL10, RANTES and IFN1β. In sharp contrast, a LXR antagonist (GSK2033) had no significant effect on VBFV replication. We conclude that LXR623 impairs flavivirus replication by stimulating cellular antiviral factors. The vector-borne flaviviruses (VBFVs) are well known for causing great misery and death in humans worldwide. The VBFVs include those transmitted by mosquitos, such as Zika virus (ZIKV), dengue virus; and those transmitted by ticks including the tick-borne flavivirus serocomplex and Powassan virus (POWV). Two of our recent reports showed that intracranial POWV infection in the reservoir host, Peromyscus leucopus, was restricted and caused no overt clinical disease. Several modes of analyses suggested activation of the LXR pathway. Activation of the LXR pathway leads to increased efflux of cholesterol from cells and consequent disturbances in membrane biogenesis. Because VBFV replication is dependent on membrane biogenesis, we evaluated the effect of an LXR agonist (LXR623) on POWV and ZIKV infection and observed that the compound impaired permissive replication of both viruses in a human neuroblastoma SK-N-SH cell line. The LXR agonist resulted in failure of the viruses to induce ER expansion and elaborate vesicle formation, suggesting that the efflux of cholesterol was part of the antiviral mechanism. We also observed that the LXR agonist contributed to the mechanism of virus suppression by increased expression of mRNAs encoding for the antiviral cytokines CXCL10, RANTES and IFN1β. In sharp contrast, a LXR antagonist (GSK2033) had no significant effect on VBFV replication. We conclude that LXR623 impairs flavivirus replication by stimulating cellular antiviral factors.The vector-borne flaviviruses (VBFVs) are well known for causing great misery and death in humans worldwide. The VBFVs include those transmitted by mosquitos, such as Zika virus (ZIKV), dengue virus; and those transmitted by ticks including the tick-borne flavivirus serocomplex and Powassan virus (POWV). Two of our recent reports showed that intracranial POWV infection in the reservoir host, Peromyscus leucopus, was restricted and caused no overt clinical disease. Several modes of analyses suggested activation of the LXR pathway. Activation of the LXR pathway leads to increased efflux of cholesterol from cells and consequent disturbances in membrane biogenesis. Because VBFV replication is dependent on membrane biogenesis, we evaluated the effect of an LXR agonist (LXR623) on POWV and ZIKV infection and observed that the compound impaired permissive replication of both viruses in a human neuroblastoma SK-N-SH cell line. The LXR agonist resulted in failure of the viruses to induce ER expansion and elaborate vesicle formation, suggesting that the efflux of cholesterol was part of the antiviral mechanism. We also observed that the LXR agonist contributed to the mechanism of virus suppression by increased expression of mRNAs encoding for the antiviral cytokines CXCL10, RANTES and IFN1β. In sharp contrast, a LXR antagonist (GSK2033) had no significant effect on VBFV replication. We conclude that LXR623 impairs flavivirus replication by stimulating cellular antiviral factors. |
| Author | Mlera, Luwanika Chiramel, Abhilash I. Dorward, David W. Bloom, Marshall E. Best, Sonja M. Offerdahl, Danielle K. Carmody, Aaron |
| Author_xml | – sequence: 1 givenname: Luwanika surname: Mlera fullname: Mlera, Luwanika email: mbloom@niaid.nih.org organization: NIAID/NIH – sequence: 2 givenname: Danielle K. orcidid: 0000-0002-0736-1664 surname: Offerdahl fullname: Offerdahl, Danielle K. organization: NIAID/NIH – sequence: 3 givenname: David W. surname: Dorward fullname: Dorward, David W. organization: NIAID/NIH – sequence: 4 givenname: Aaron surname: Carmody fullname: Carmody, Aaron organization: NIAID/NIH – sequence: 5 givenname: Abhilash I. surname: Chiramel fullname: Chiramel, Abhilash I. organization: NIAID/NIH – sequence: 6 givenname: Sonja M. surname: Best fullname: Best, Sonja M. organization: NIAID/NIH – sequence: 7 givenname: Marshall E. surname: Bloom fullname: Bloom, Marshall E. email: luwanikamlera@arizona.edu organization: NIAID/NIH |
| BookMark | eNqFkV9rFDEUxYNUbK39CMKAL77smr-TBEEspbaFBUEq9C3cyWS2WbKTNZlZ6bc309mC7YPmJeGec39J7nmLjvrYO4TeE7wkWOFPtCwiBVlSTMmSaC4l16_QyVRfTMLRX-djdJbzBpclcc0Jf4OOGSc1ZVidoMvbe1cFv3epuquSs243xFTBOvY-D9Xq7kdVjEXIQ_J2yFUXYO_3Po25FHfBWxh87N-h1x2E7M4O-yn6-e3y9uJ6sfp-dXNxvlpYwfSw0IrKpsUCoMU10Y46CY2UUHcgiCqSkEXsOBG1FbyrbcOEpNw1AEI3mrBTdDNz2wgbs0t-C-nBRPDmsRDT2kAavA3OtLxVmnYYGCjuqNJMNthxJoEDNF1TWF9m1m5stq61rh8ShGfQ50rv78067o2iQqtaFsDHAyDFX2OZkNn6bF0I0Ls4ZkMF50pqxibrhxfWTRxTX0ZlGNGYUzUDP88um2LOyXXG-uFxvuV-HwzBZkrfPKVvpvTNIf3SLV50P33lf31f5z7fdzFt4XdMoTUDPISYugS99dMj_4n4A8pkxbQ |
| CitedBy_id | crossref_primary_10_12688_f1000research_132627_3 crossref_primary_10_13005_bpj_2960 crossref_primary_10_1186_s12985_022_01853_8 crossref_primary_10_12688_f1000research_132627_2 crossref_primary_10_1186_s12985_025_02622_z crossref_primary_10_12688_f1000research_132627_1 crossref_primary_10_1016_j_vetmic_2023_109952 crossref_primary_10_1016_j_isci_2024_109088 crossref_primary_10_3389_fphys_2021_750544 crossref_primary_10_3390_v14030514 |
| Cites_doi | 10.1016/j.chom.2016.03.010 10.1128/aac.01578-15 10.1016/j.virol.2016.11.002 10.1371/journal.ppat.1006952 10.1128/JVI.00856-16 10.1056/NEJMoa1600651 10.1128/jvi.02277-15 10.1038/srep39775 10.3389/fcimb.2018.00388 10.1038/s41467-017-02645-3 10.1128/jvi.78.6.2701-2710.2004 10.1371/journal.pntd.0005346 10.3390/v3020160 10.1016/j.virol.2009.03.025 10.1093/eurheartj/ehr136 10.1093/infdis/jiy129 10.1371/journal.pone.0047912 10.1016/j.celrep.2016.05.075 10.1074/jbc.M703278200 10.1016/j.virol.2017.03.016 10.4049/jimmunol.1201393 10.1016/j.phrs.2014.03.002 10.1128/AAC.01220-19 10.1007/s13365-017-0596-y 10.1038/srep25481 10.1016/j.celrep.2016.08.038 10.1159/000163368 10.1161/CIRCRESAHA.110.226878 10.1016/j.coviro.2014.09.020 10.1016/0166-0934(95)01916-2 10.1159/000321892 10.1016/j.chom.2007.09.003 10.1038/s41598-018-32400-7 10.1016/S0166-3542(02)00206-1 10.1016/j.bbadis.2010.12.015 10.3402/iee.v3i0.19839 10.1038/nature12060 10.1053/j.semdp.2019.04.009 10.1146/annurev-immunol-042617-053142 10.1016/j.plipres.2016.09.005 10.1016/j.chom.2018.05.005 10.1016/S0092-8674(00)81432-4 10.1016/j.chom.2016.09.006 10.1096/fj.201600244R 10.1128/JVI.79.20.12828-12839.2005 10.1089/vbz.2017.2110 10.1016/j.stem.2016.04.014 10.1038/nrmicro.2017.170 10.1016/j.antiviral.2015.10.013 10.3389/fmicb.2017.02286 10.1038/emi.2017.67 10.1172/JCI27883 10.1158/0008-5472.Can-04-2332 10.1371/journal.pone.0087412 10.1097/wco.0000000000000471 10.1371/journal.pone.0200358 10.1002/1873-3468.12702 10.1111/cmi.12884 |
| ContentType | Journal Article |
| Copyright | 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2021 This work was authored as part of the Contributor's official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law. . This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2021 The Author(s) |
| Copyright_xml | – notice: 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2021 – notice: This work was authored as part of the Contributor's official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law. . This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2021 The Author(s) |
| DBID | 0YH AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1080/22221751.2021.1947749 |
| DatabaseName | Taylor & Francis Free Journals (Free resource, activated by CARLI) CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 0YH name: Taylor & Francis Free Journals (Free resource, activated by CARLI) url: https://www.tandfonline.com sourceTypes: Publisher – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| DocumentTitleAlternate | EMERGING MICROBES AND INFECTIONS |
| EISSN | 2222-1751 |
| EndPage | 1389 |
| ExternalDocumentID | oai_doaj_org_article_d4d892f0a3a84e28937b0e437a4aabfb PMC8259867 10_1080_22221751_2021_1947749 1947749 |
| Genre | Research Article |
| GrantInformation_xml | – fundername: NIH – fundername: NIAID funderid: 10.13039/100000060 |
| GroupedDBID | 0YH 3V. 53G 5VS 7X7 8FI AAHBH ACGFS ADBBV ADRAZ AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BENPR BPHCQ BVXVI C6C DIK EBS ECGQY EMOBN FYUFA GROUPED_DOAJ HYE KQ8 M1P M48 M4Z M~E NAO OK1 PIMPY PQQKQ PROAC RNT RNTTT RPM TDBHL UKHRP 88E 8FJ AAYXX ABUWG BCNDV CCPQU CITATION EJD HMCUK PHGZM PHGZT PSQYO 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c539t-9827bd05aad0619e2e7ab77a6fa5187bd5705af4156c54f6cb35724ebaa59b913 |
| IEDL.DBID | M48 |
| ISSN | 2222-1751 |
| IngestDate | Wed Aug 27 00:55:41 EDT 2025 Thu Aug 21 18:16:51 EDT 2025 Fri Jul 11 06:06:05 EDT 2025 Fri Jul 25 10:50:06 EDT 2025 Tue Jul 01 04:51:29 EDT 2025 Thu Apr 24 22:52:33 EDT 2025 Wed Dec 25 09:06:04 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c539t-9827bd05aad0619e2e7ab77a6fa5187bd5705af4156c54f6cb35724ebaa59b913 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 These authors contributed equally to this work. Present address: BIO5 Institute, University of Arizona, Tucson, AZ 85719, USA. |
| ORCID | 0000-0002-0736-1664 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1080/22221751.2021.1947749 |
| PMID | 34162308 |
| PQID | 3190428867 |
| PQPubID | 2041957 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_2544879337 crossref_citationtrail_10_1080_22221751_2021_1947749 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8259867 proquest_journals_3190428867 crossref_primary_10_1080_22221751_2021_1947749 doaj_primary_oai_doaj_org_article_d4d892f0a3a84e28937b0e437a4aabfb informaworld_taylorfrancis_310_1080_22221751_2021_1947749 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-01-01 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London |
| PublicationTitle | Emerging microbes & infections |
| PublicationYear | 2021 |
| Publisher | Taylor & Francis Taylor & Francis Ltd Taylor & Francis Group |
| Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Ltd – name: Taylor & Francis Group |
| References | e_1_3_3_52_1 e_1_3_3_50_1 Biedler JL (e_1_3_3_40_1) 1978; 38 e_1_3_3_18_1 e_1_3_3_39_1 e_1_3_3_14_1 e_1_3_3_37_1 e_1_3_3_16_1 e_1_3_3_35_1 e_1_3_3_58_1 e_1_3_3_10_1 e_1_3_3_33_1 e_1_3_3_56_1 e_1_3_3_12_1 e_1_3_3_31_1 e_1_3_3_54_1 e_1_3_3_61_1 e_1_3_3_7_1 e_1_3_3_9_1 e_1_3_3_29_1 e_1_3_3_25_1 e_1_3_3_48_1 e_1_3_3_27_1 e_1_3_3_46_1 e_1_3_3_3_1 e_1_3_3_21_1 e_1_3_3_44_1 e_1_3_3_5_1 e_1_3_3_23_1 e_1_3_3_42_1 e_1_3_3_30_1 e_1_3_3_51_1 e_1_3_3_17_1 e_1_3_3_19_1 e_1_3_3_13_1 e_1_3_3_38_1 e_1_3_3_59_1 e_1_3_3_15_1 e_1_3_3_36_1 e_1_3_3_57_1 e_1_3_3_34_1 e_1_3_3_55_1 e_1_3_3_11_1 e_1_3_3_32_1 e_1_3_3_53_1 e_1_3_3_41_1 e_1_3_3_60_1 e_1_3_3_6_1 e_1_3_3_8_1 e_1_3_3_28_1 e_1_3_3_24_1 e_1_3_3_49_1 e_1_3_3_26_1 e_1_3_3_47_1 e_1_3_3_2_1 e_1_3_3_20_1 e_1_3_3_45_1 e_1_3_3_4_1 e_1_3_3_22_1 e_1_3_3_43_1 |
| References_xml | – ident: e_1_3_3_42_1 doi: 10.1016/j.chom.2016.03.010 – ident: e_1_3_3_37_1 doi: 10.1128/aac.01578-15 – ident: e_1_3_3_14_1 doi: 10.1016/j.virol.2016.11.002 – ident: e_1_3_3_16_1 doi: 10.1371/journal.ppat.1006952 – ident: e_1_3_3_52_1 doi: 10.1128/JVI.00856-16 – ident: e_1_3_3_5_1 doi: 10.1056/NEJMoa1600651 – ident: e_1_3_3_56_1 doi: 10.1128/jvi.02277-15 – ident: e_1_3_3_29_1 doi: 10.1038/srep39775 – ident: e_1_3_3_33_1 doi: 10.3389/fcimb.2018.00388 – ident: e_1_3_3_25_1 doi: 10.1038/s41467-017-02645-3 – ident: e_1_3_3_43_1 doi: 10.1128/jvi.78.6.2701-2710.2004 – ident: e_1_3_3_22_1 doi: 10.1371/journal.pntd.0005346 – ident: e_1_3_3_10_1 doi: 10.3390/v3020160 – ident: e_1_3_3_36_1 doi: 10.1016/j.virol.2009.03.025 – ident: e_1_3_3_57_1 doi: 10.1093/eurheartj/ehr136 – ident: e_1_3_3_24_1 doi: 10.1093/infdis/jiy129 – ident: e_1_3_3_12_1 doi: 10.1371/journal.pone.0047912 – ident: e_1_3_3_27_1 doi: 10.1016/j.celrep.2016.05.075 – ident: e_1_3_3_49_1 doi: 10.1074/jbc.M703278200 – ident: e_1_3_3_23_1 doi: 10.1016/j.virol.2017.03.016 – ident: e_1_3_3_51_1 doi: 10.4049/jimmunol.1201393 – ident: e_1_3_3_53_1 doi: 10.1016/j.phrs.2014.03.002 – ident: e_1_3_3_61_1 doi: 10.1128/AAC.01220-19 – ident: e_1_3_3_19_1 doi: 10.1007/s13365-017-0596-y – ident: e_1_3_3_47_1 doi: 10.1038/srep25481 – ident: e_1_3_3_59_1 doi: 10.1016/j.celrep.2016.08.038 – ident: e_1_3_3_34_1 doi: 10.1371/journal.ppat.1006952 – ident: e_1_3_3_41_1 doi: 10.1159/000163368 – volume: 38 start-page: 3751 year: 1978 ident: e_1_3_3_40_1 article-title: Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones publication-title: Cancer Res – ident: e_1_3_3_26_1 doi: 10.1161/CIRCRESAHA.110.226878 – ident: e_1_3_3_9_1 doi: 10.1016/j.coviro.2014.09.020 – ident: e_1_3_3_13_1 doi: 10.1016/0166-0934(95)01916-2 – ident: e_1_3_3_54_1 doi: 10.1159/000321892 – ident: e_1_3_3_35_1 doi: 10.1016/j.chom.2007.09.003 – ident: e_1_3_3_39_1 doi: 10.1038/s41598-018-32400-7 – ident: e_1_3_3_7_1 doi: 10.1016/S0166-3542(02)00206-1 – ident: e_1_3_3_46_1 doi: 10.1016/j.bbadis.2010.12.015 – ident: e_1_3_3_2_1 doi: 10.3402/iee.v3i0.19839 – ident: e_1_3_3_3_1 doi: 10.1038/nature12060 – ident: e_1_3_3_4_1 doi: 10.1053/j.semdp.2019.04.009 – ident: e_1_3_3_45_1 doi: 10.1146/annurev-immunol-042617-053142 – ident: e_1_3_3_31_1 doi: 10.1016/j.plipres.2016.09.005 – ident: e_1_3_3_18_1 doi: 10.1016/j.chom.2018.05.005 – ident: e_1_3_3_21_1 doi: 10.1016/S0092-8674(00)81432-4 – ident: e_1_3_3_60_1 doi: 10.1016/j.chom.2016.09.006 – ident: e_1_3_3_50_1 doi: 10.1096/fj.201600244R – ident: e_1_3_3_44_1 doi: 10.1128/JVI.79.20.12828-12839.2005 – ident: e_1_3_3_8_1 doi: 10.1089/vbz.2017.2110 – ident: e_1_3_3_58_1 doi: 10.1016/j.stem.2016.04.014 – ident: e_1_3_3_15_1 doi: 10.1038/nrmicro.2017.170 – ident: e_1_3_3_17_1 doi: 10.1016/j.antiviral.2015.10.013 – ident: e_1_3_3_32_1 doi: 10.3389/fmicb.2017.02286 – ident: e_1_3_3_28_1 doi: 10.1038/emi.2017.67 – ident: e_1_3_3_20_1 doi: 10.1172/JCI27883 – ident: e_1_3_3_30_1 doi: 10.1158/0008-5472.Can-04-2332 – ident: e_1_3_3_55_1 doi: 10.1371/journal.pone.0087412 – ident: e_1_3_3_6_1 doi: 10.1097/wco.0000000000000471 – ident: e_1_3_3_38_1 doi: 10.1371/journal.pone.0200358 – ident: e_1_3_3_48_1 doi: 10.1002/1873-3468.12702 – ident: e_1_3_3_11_1 doi: 10.1111/cmi.12884 |
| SSID | ssj0000706414 |
| Score | 2.2334871 |
| Snippet | The vector-borne flaviviruses (VBFVs) are well known for causing great misery and death in humans worldwide. The VBFVs include those transmitted by mosquitos,... |
| SourceID | doaj pubmedcentral proquest crossref informaworld |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 1378 |
| SubjectTerms | Biosynthesis Dengue fever Flavivirus liver X receptor LXR 623 Powassan virus virus restriction Viruses Zika virus |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhp0IofSR0mwcq9OrE1sOyjm1ICKHtISSwNzGSpWRh8YasN7-_M7Z3Weeyl5wMGklYo9E89PiGsZ9BaZm0NFnKwWSqKlQG1shMGZViMDkoQW-H__4rbx7U7VRPt1J90Z2wHh64Z9xFrerKCuxJQqWiIPPq86ikAQXgkyftizZvK5jqdLBBU1uo9ZOdKr9AO4jet6aQUBTnGLqj32NHxqjD7H-DWDryO8e3JrfM0PUn9nHwH_mv_r8_s73YfGEH_eYb798UfWVXOPl8Tjcu-JSjSovPGFlzeFwQTC7_M73j6I5wysqBWrBd8jSH19nr7GW1xMLNgfYhe7i-ur-8yYZ8CVnQ0raZrYTxda4BarTSNopowBsDZQJdVEjSBomJQragVSqDl9oIFT2Att4W8ojtN4smfmM8JRukTCW6c0LJvIYkQkJvBvuhb5gwtWacCwOYOOW0mLtiwBxd89sRv93A7wk73zR77tE0djX4TbOyqUxg2F0BiogbRMTtEpEJs9tz6tpuLyT1iUuc3PEDJ2sBcMPqpiaWQs2qNBP2Y0PGdUmHLdDExWrpCPqtQuUnsY4ZCc5oMGNKM3vqEL4xbLfY-_f3GP0x-0AD6reNTth--7KKp-hItf6sWzP_AbIIFtg priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagXJAQ4imWFmQkrmkTP-L4VAFqVSHggKiUm2U7dllplSy72f5-ZhInajjQUyQ_Escej78Z298Q8tELyaPkKou5VZmoCpFZrXgmlIjBq9wKhneHv_8or67F11rWyeG2T8cqJ504KOqm8-gjPwNRQXhflep8-yfDqFG4u5pCaDwkj5C6DI90qVrNPhYQ51IUYrq4U-VnsBoCBpdoGLLiFAx4QD96sSQNzP3_8JYu0Ofy7OSdxejyGXmaUCT9NA77c_IgtC_Ik9EFR8ebRS_JBYgA3eC5C1pTUGxhC_Y1tTcdkuXSb_VPCqCEYmwO0IX9nsaNvV3frneHPSTO29qvyPXlxa8vV1mKmpB5yXWf6Yop1-TS2gbWah1YUNYpZctoZVFBllSQGdFw81LE0jsuFRPBWSu10wV_TY7arg1vCI1Re85jCaCOCZ43NjIfAdPAe_DpV0RMHWd8ohTHyBYbUyTm0am_Dfa3Sf29Iqdzte3IqXFfhc84KnNhpMQeErrdjUkzzDSiqTQDkeO2EoEhDnN5EFxZYa2LbkX03TE1_eARiWP4EsPvacDJJAAmzXGsMknkinyYs2F24paLbUN32BskgKtABXIooxaCs_iZZU67_j3wfIPxruHtb___8WPyGJs6uoVOyFG_O4R3AJR6936YDX8BUDUNlw priority: 102 providerName: ProQuest – databaseName: Taylor & Francis Free Journals (Free resource, activated by CARLI) dbid: 0YH link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEBZteimU0CfdJC0q9OrU1sOyjmlJWELaQ2lgexIjW0oXFm9Ye_P7M-MXcaHk0JOx9UAezUjfSKNPjH0ulZZRS5PEFEyiikwlYI1MlFExlCYFJejs8Pcf-fJaXa70GE3YDGGV5EPHniiiG6vJuME3Y0TcF5zSEEhr8u5EdopeOEIY-5Q9E6StqNLp7-W0zIIanatMjWd3_lV6Nit15P1_UZfOAOg8fPLBfHTxkh0OQJKf9T3_ij0J9Wv2ol-F4_3hojfsHLWAbyj0gq84jm3hFl1sDjdb4svlV6ufHHEJp-s5cDhsGx43cLe-W-_2DX6cdrbfsuuL81_flslwcUJSamnbxBbC-CrVABVO1zaIYMAbA3kEnRWYpA0mRvLdSq1iXnqpjVDBA2jrbSbfsYN6W4f3jMdoSyljjrhOKJlWEEUZEdZgPfQsF0yNgnPlwCpOl1tsXDaQj47ydiRvN8h7wU6nYrc9rcZjBb5Sr0yZiRW7-7Dd3bjByFylqsIK1DoJhQqCoJhPg5IGFICPfsHswz51bbcoEvsbTJx8pAEnowK4wcypiCWfs8jNgn2aktFAadcF6rDdN4444AocBSXmMTPFmf3MPKVe_-movtF_t1j70X80_Jg9p9d-2eiEHbS7ffiAQKr1HztTuQfp0BLa priority: 102 providerName: Taylor & Francis |
| Title | The liver X receptor agonist LXR 623 restricts flavivirus replication |
| URI | https://www.tandfonline.com/doi/abs/10.1080/22221751.2021.1947749 https://www.proquest.com/docview/3190428867 https://www.proquest.com/docview/2544879337 https://pubmed.ncbi.nlm.nih.gov/PMC8259867 https://doaj.org/article/d4d892f0a3a84e28937b0e437a4aabfb |
| Volume | 10 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEB7yuBRKSF9003RRoVdvbT0s61BKUjYspQkldME9CcmW0oXFm-56Q_vvO_JjiUtLDr3YWLKMPZ7RfKPHNwBvCy6YF0xGPjYy4lnCI6Mki7jk3hUyNpyGvcOXV-lszj_lIt-DnlChE-Dmr6FdyCc1Xy8nP3_8-oAG_75bIfcOXRwCaxGiPZpMMCpHSKP24RCdkwy2etkh_qZzluiDE97v5flX64GXasj8_6AyHQDS4XLKe_7p4hiOOmBJzlpNeAJ7rnoKj9tROdJuNnoGU9QKsgxLMUhOsK9ztxhyE3OzCvy55HN-TRCnkJCuA7vHekP80twt7hbr7QYLdzPdz2F-Mf36cRZ1iRSiQjBVRyqj0paxMKZE960cddJYKU3qjUgyrBISK32I5QrBfVpYJiTlzhojlFUJewEH1apyL4F4rwrGfIo4j3IWl8bTwiPMweeEczEC3gtOFx3LeEh2sdRJR0bay1sHeetO3iOY7JrdtjQbDzU4D39ld3NgyW4KVusb3RmdLnmZKYpayEzGHQ3QzMaOM2m4MdbbEaj7_1TXzSCJbzOaaPbAC5z2CqB7rcUmKsSgWSpH8GZXjQYbZmFM5VbbjQ6ccBn2igzvkQPFGXzMsKZafG-ovzGeV_j0k_948VfwKFy2w0incFCvt-41AqvajmE__jbDo8zlGA7Pp1dfrsfNIMW4MaLfDzcd4w |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbK9gASQjzFQgEjwTFt4kccHxCisNWWbleoaqW9GSexy0qrZNlHEX-K38hMXmo40FNPK8VxNhnPjL8Z298Q8i4TknvJVeBDqwKRRCKwWvFAKOFdpkIrGJ4dPp3G4wvxdSZnO-RPexYGt1W2PrFy1HmZYY78AFQF4X0Sq4_LnwFWjcLV1baERq0WJ-73LwjZ1h-Ov8D4vmfsaHT-eRw0VQWCTHK9CXTCVJqH0toc5jLtmFM2VcrG3soogSapoNFjYJNJ4eMs5VIx4VJrpU51xOG5d8iu4BDKDMju4Wj67azL6oABxSIS7VGhJDyA-RdQv8RQlEX7kRaAt3RvEqxqBfzDlNrDu_3dmtemv6OH5EGDW-mnWtEekR1XPCb366Qfrc8yPSEjUDq6wJ0edEbBlbolRPTUXpZIz0snszMKMIhiNRDwvps19Qt7Nb-ar7ZruNgtpD8lF7ci0WdkUJSFe06o9zrj3McAI5ngYW49yzygKHgO_mZDIlrBmawhMcdaGgsTNVynrbwNyts08h6S_a7bsmbxuKnDIY5KdzOScFcXytWlaWza5CJPNAMl5zYRjiHyS0MnuLLC2tSnQ6Kvj6nZVDkYXxdMMfyGF9hrFcA0XgW7tDYwJG-7ZvAHuMhjC1du1wYp5xJwuhzuUT3F6X1Mv6WY_6iYxROGdP3qxf___A25Oz4_nZjJ8fTkJbmHr10npfbIYLPaulcA0zbp68Y2KPl-2-b4F551TAY |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEBZtCqVQQvqi2zyqQq9ObUuyrGMfWTZtGkppYHsSI1tKFhbvsuvN7--MX8SFkkNPBo8kZGlG8408-sTY-0IqEZTQUYhBRzJPZARGi0hqGXyhY5ApnR3-fpnNruTXueqzCbddWiXF0KElimjWajLudRn6jLgP6NIQSCuK7tLkFKNwhDDmIXukcvT1qNLx79mwzYIanclE9md3_lV75JUa8v6_qEtHAHScPnnHH00P2H4HJPnHduafsQe-es6etrtwvD1c9IKdoRbwJaVe8DnHtc2vMcTmcL0ivlx-Mf_JEZdwup4Dl8N6y8MSbhe3i81uiy-HP9sv2dX07NfnWdRdnBAVSpg6MnmqXRkrgBLdtfGp1-C0hiyASnIUKY3CQLFboWTICieUTqV3AMo4k4hXbK9aVf414yGYQoiQIa5LpYhLCGkRENZgO_QsJkz2A2eLjlWcLrdY2qQjH-3H29J42268J-x0qLZuaTXuq_CJZmUoTKzYzYvV5tp2RmZLWaIKoNYJyKVPCYq52EuhQQK44CbM3J1TWzebIqG9wcSKezpw1CuA7cycqhiKOfNMT9i7QYwGSn9doPKr3dYSB1yOq6DAMnqkOKOPGUuqxU1D9Y3xu8HW3_xHx9-yxz--TO3F-eW3Q_aEJO0O0hHbqzc7f4yYqnYnjdX8ASEiFYA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+liver+X+receptor+agonist+LXR+623+restricts+flavivirus+replication&rft.jtitle=Emerging+microbes+%26+infections&rft.au=Mlera%2C+Luwanika&rft.au=Offerdahl%2C+Danielle+K.&rft.au=Dorward%2C+David+W.&rft.au=Carmody%2C+Aaron&rft.date=2021-01-01&rft.pub=Taylor+%26+Francis&rft.eissn=2222-1751&rft.volume=10&rft.issue=1&rft.spage=1378&rft.epage=1389&rft_id=info:doi/10.1080%2F22221751.2021.1947749&rft.externalDBID=0YH&rft.externalDocID=1947749 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2222-1751&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2222-1751&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2222-1751&client=summon |